Your Cart ( 1 Item )

• Topical Calcipotriene 0.005% and Betamethasone Dipropionate 0.064% Maintains Efficacy of Etanercept After Step-Down Dose in Patients With Moderate-to-Severe Plaque Psoriasis: Results of an Open Label Trial
  August 2011 | Volume 10 | Issue 8 | Original Article | 878 | Copyright © August 2011
  

  Leon H. Kircik MD^a,b

  
  You will have 48 hours to download the full-text PDF

  Price

  24.95

  Term

  48 Hrs